We speculated that the effect of IL-17A on WT-EGFR NSCLC might be different from that on mutant-EGFR NSCLC as mutant-EGFR is constitutively activated but WT-EGFR is not. This evidence concerns the gene IL17A and non-small cell lung carcinoma.